AUROBINDO PHARMA
|
The Current P/S Ratio of AUROBINDO PHARMA is 2.12.
| Share Price | ₹1,211.4 | Mar 02,2026 |
| Market Cap | ₹70,355.2 Cr | |
| Sales-TTM | ₹33,181.9 Cr | TTM-Consolidated Results |
| Price/Sales | 2.12x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of AUROBINDO PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹70,355.2 Cr] as on Mar 02,2026
(/) Sales [ ₹33,181.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.12x ]
Thus, for AUROBINDO PHARMA , the investors are currently willing to pay '2.12 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of AUROBINDO PHARMA !
The chart below summarizes the trend in P/S Ratio of AUROBINDO PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of AUROBINDO PHARMA
PS Ratio Performance Analysis for AUROBINDO PHARMA
- AUROBINDO PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.86x.
- AUROBINDO PHARMA 's operated at median p/e ratio of 2.08x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AUROBINDO PHARMA 's p/e ratio peaked in Mar2024 at 2.2x.
- AUROBINDO PHARMA 's p/e ratio hit its five-year low in Mar2023 of 1.22x.
How does AUROBINDO PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| AUROBINDO PHARMA | 33,181.9 | 2.12 | 70,355.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.40 | 420,531.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.48 | 169,989.0 |
| CIPLA LTD | 28,351.1 | 3.85 | 109,200.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.61 | 147,936.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.12 | 108,057.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.66 | 92,672.7 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.50 | 91,250.3 |
| LUPIN LTD | 26,150.5 | 4.04 | 105,650.0 |
| ABBOTT INDIA LTD | 6,824.1 | 8.35 | 57,006.5 |
| ALKEM LABORATORIES LTD | 14,252.7 | 4.68 | 66,663.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AUROBINDO PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.12x |
| Max industry PS | 16.48x |
| Median industry PS | 4.68x |
| Average industry PS | 6.53x |
You may also like the below Video Courses